Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 3
1998 3
1999 1
2000 1
2001 2
2002 1
2003 3
2004 1
2005 2
2006 3
2007 4
2008 4
2009 9
2010 6
2011 6
2012 11
2013 8
2014 11
2015 11
2016 11
2017 16
2018 16
2019 8
2020 9
2021 10
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. de Koning HJ, et al. Among authors: nackaerts k. N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995683 Clinical Trial.
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
Franken A, Van Mol P, Vanmassenhove S, Donders E, Schepers R, Van Brussel T, Dooms C, Yserbyt J, De Crem N, Testelmans D, De Wever W, Nackaerts K, Vansteenkiste J, Vos R, Humblet-Baron S, Lambrechts D, Wauters E. Franken A, et al. Among authors: nackaerts k. J Immunother Cancer. 2022 Sep;10(9):e005323. doi: 10.1136/jitc-2022-005323. J Immunother Cancer. 2022. PMID: 36171010 Free PMC article.
Lung Cancer in Belgium.
Ocak S, Tournoy K, Berghmans T, Demedts I, Durieux R, Janssens A, Moretti L, Nackaerts K, Pieters T, Surmont V, Van Eycken L, Vrijens F, Weynand B, van Meerbeeck JP. Ocak S, et al. Among authors: nackaerts k. J Thorac Oncol. 2021 Oct;16(10):1610-1621. doi: 10.1016/j.jtho.2021.07.022. J Thorac Oncol. 2021. PMID: 34561034 Free article. No abstract available.
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study.
Blackhall F, Jao K, Greillier L, Cho BC, Penkov K, Reguart N, Majem M, Nackaerts K, Syrigos K, Hansen K, Schuette W, Cetnar J, Cappuzzo F, Okamoto I, Erman M, Langer SW, Kato T, Groen H, Sun Z, Luo Y, Tanwani P, Caffrey L, Komarnitsky P, Reinmuth N. Blackhall F, et al. Among authors: nackaerts k. J Thorac Oncol. 2021 Sep;16(9):1547-1558. doi: 10.1016/j.jtho.2021.02.009. Epub 2021 Feb 16. J Thorac Oncol. 2021. PMID: 33607312 Free article. Clinical Trial.
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators. Peters S, et al. Among authors: nackaerts k. Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23. Ann Oncol. 2022. PMID: 34562610 Free article. Clinical Trial.
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.
von Pawel J, Jotte R, Spigel DR, O'Brien ME, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM, Clingan P, Schütte W, Lorigan P, Reck M, Domine M, Shepherd FA, Li S, Renschler MF. von Pawel J, et al. Among authors: nackaerts k. J Clin Oncol. 2014 Dec 10;32(35):4012-9. doi: 10.1200/JCO.2013.54.5392. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385727 Clinical Trial.
Quantifying asbestos in lung tissue: what debate?
Nemery B, Nuyts V, Nackaerts K. Nemery B, et al. Among authors: nackaerts k. Eur Respir J. 2017 Jun 29;49(6):1700861. doi: 10.1183/13993003.00861-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28663320 Free article. No abstract available.
Hotspots of malignant pleural mesothelioma in Western Europe.
Nuyts V, Nawrot T, Nemery B, Nackaerts K. Nuyts V, et al. Among authors: nackaerts k. Transl Lung Cancer Res. 2018 Oct;7(5):516-519. doi: 10.21037/tlcr.2018.10.01. Transl Lung Cancer Res. 2018. PMID: 30450289 Free PMC article. Review.
An uncommon histopathological diagnosis.
Bode H, Sciot R, Werbrouck E, Geusens E, Deroose CM, Nackaerts K. Bode H, et al. Among authors: nackaerts k. Breathe (Sheff). 2018 Dec;14(4):311-316. doi: 10.1183/20734735.027418. Breathe (Sheff). 2018. PMID: 30519297 Free PMC article.
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial.
Sidorenkov G, Stadhouders R, Jacobs C, Mohamed Hoesein FAA, Gietema HA, Nackaerts K, Saghir Z, Heuvelmans MA, Donker HC, Aerts JG, Vermeulen R, Uitterlinden A, Lenters V, van Rooij J, Schaefer-Prokop C, Groen HJM, de Jong PA, Cornelissen R, Prokop M, de Bock GH, Vliegenthart R. Sidorenkov G, et al. Among authors: nackaerts k. Eur J Epidemiol. 2023 Apr;38(4):445-454. doi: 10.1007/s10654-023-00975-9. Epub 2023 Mar 21. Eur J Epidemiol. 2023. PMID: 36943671 Free PMC article. Clinical Trial.
159 results